Trademark Overview
On Thursday, November 7, 2024, a trademark application was filed for BREATHBIOMICS with the United States Patent and Trademark Office. The USPTO has given the BREATHBIOMICS trademark a serial number of 98842819. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 7, 2024. This trademark is owned by Zeteo Tech, Inc.. The BREATHBIOMICS trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Medical Instrument Products categories with the following description:
Scientific apparatus, namely, mass spectrometers and parts thereof, in particular, time-of-flight mass spectrometers and aerosol time-of-flight mass spectrometers; computer programs and computer software for operating mass spectrometers; computer programs and computer software, in particular, deep learning algorithms, for analyzing and displaying spectral data recorded by mass spectrometers, in particular, to identify chemicals, biological molecules such as peptide and proteins, and microorganisms, such as bacteria, yeasts, viruses or fungi, in aerosol analytes, biological, chemical, industrial and food samples
Diagnostic instruments, in particular, mass spectrometer systems for identifying chemicals, biological molecules such as peptide and proteins, and microorganisms, such as bacteria, yeasts, viruses or fungi, in aerosol analytes, biological, chemical, industrial and food samples for use in the identification of pathogens that cause infectious diseases and food-borne diseases, identification of pathogens in the point of care diagnostics market, and identification of biological and chemical threat agents; aerosol sample collection devices and sample preparation devices, in particular, for mass spectrometry, time-of-flight mass spectrometry and aerosol time-of-flight mass spectrometry for use in the identification of pathogens that cause infectious diseases and food-borne diseases, identification of pathogens in the point of care diagnostics market, and identification of biological and chemical threat agents